The DES Center

Filter Your Results

 

News

 

TRANSFORM-OCT Evaluates Strut Coverage and Neoatherosclerosis in Bioresorbable Versus Durable Polymer DES

November 2, 2016 -- Results from TRANSFORM-OCT, a prospective, randomized trial that used optical coherence tomography (OCT) to evaluate strut coverage and neoatherosclerosis …

Three-year EXCEL Data Evaluate Abbott Vascular’s EES in Left Main CAD

October 31, 2016 -- Three-year results from the EXCEL trial were presented at TCT 2016, the 28th annual Transcatheter Cardiovascular Therapeutics scientific symposium in Washi…

First-in-Human REVELUTION Data Presented for Medtronic’s Drug-Filled Stent

October 31, 2016 -- The first-in-human REVELUTION study of Medtronic plc’s new polymer-free, drug-filled stent (DFS) indicated noninferior in-stent late lumen loss at 9-…

FANTOM II Results Presented for Reva Medical’s Fantom Bioresorbable Vascular Scaffold

October 31, 2016 -- The FANTOM II study was presented during the First Report Investigations presentations on bioresorbable stent technologies at TCT 2016, the 28th annua…

Meril’s MeRes100 Bioresorbable Vascular Scaffold Demonstrates 6-Month Safety and Efficacy

October 31, 2016 -- The MeRes-1 study was presented during the First Report Investigations presentations on bioresorbable stent technologies at TCT 2016, the 28th annual Trans…

First-in-Man FUTURE-I Study Assesses Shanghai Microport’s Firesorb Bioresorbable Vascular Scaffold

October 31, 2016 -- The FUTURE-I study was presented by Bo Xu, MBBS, during the First Report Investigations session on bioresorbable stent technologies at TCT 2016, the 28th a…

Very Thin Strut Biodegradable Polymer DES Compared With Durable DES in BIO-RESORT Trial

October 30, 2016 -- Results of BIO-RESORT (TWENTE III), a large-scale, multicenter study found that treatment with two thin-strut drug-eluting stents were noninferior to a dur…

One-Year BIONICS Data Presented for Medinol’s BioNIR Ridaforolimus-Eluting Stent

October 30, 2016 -- The large multinational randomized BIONICS study found that the BioNIR ridaforolimus-eluting stent (Medinol, Ltd,) was noninferior to a zotarolimus-el…

 

advertisement

 

Contact Info

For advertising rates and opportunities, contact:
Craig McChesney
484-581-1816
cmcchesney@bmctoday.com

Stephen Hoerst
484-581-1817
shoerst@bmctoday.com

Charles Philip
484-581-1873
cphillip@bmctoday.com

About Cardiac Interventions Today

Cardiac Interventions Today is a publication dedicated to providing comprehensive coverage of the latest developments in technology, techniques, clinical studies, and regulatory and reimbursement issues in the field of coronary and cardiac interventions. Cardiac Interventions Today premiered in March 2007, with its launch issue focusing on the state of coronary drug-eluting stent use. Each edition will cover a variety of topics in a flexible format that includes articles covering various perspectives on current clinical topics, in-depth interviews with expert physicians, overviews of available technologies, industry news, and insights into the issues affecting today's cardiology practices.